This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Jan;12(1):4.

doi: 10.1038/nrclinonc.2014.214. Epub 2014 Dec 2.

Breast cancer. Risedronate reduces bone loss

Robert Phillips

PMID: 25445560
DOI: 10.1038/nrclinonc.2014.214

Comment

Breast cancer. Risedronate reduces bone loss

Robert Phillips. Nat Rev Clin Oncol. 2015 Jan.

. 2015 Jan;12(1):4.

doi: 10.1038/nrclinonc.2014.214. Epub 2014 Dec 2.

Author

Robert Phillips

PMID: 25445560
DOI: 10.1038/nrclinonc.2014.214

No abstract available

PubMed Disclaimer

Comment on

Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trial.
Sestak I, Singh S, Cuzick J, Blake GM, Patel R, Gossiel F, Coleman R, Dowsett M, Forbes JF, Howell A, Eastell R. Sestak I, et al. Lancet Oncol. 2014 Dec;15(13):1460-1468. doi: 10.1016/S1470-2045(14)71035-6. Epub 2014 Nov 11. Lancet Oncol. 2014. PMID: 25456365 Clinical Trial.

References

1. Lancet Oncol. 2014 Dec;15(13):1460-8 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information